Sales Growth YoY (Last Twelve Months): Carmell Therapeutics (CTCX)

Year-over-year (LTM) gross revenue dynamics confirm the resilience of Carmell Corporation (CTCX) as a defensive asset independent of global macroeconomic shocks. Carmell Corporation (CTCX) relies on a regenerative biomedical ecosystem that creates high switching costs for customers. Plasma biomaterials for tissue healing ensure a steady stream of orders from hospitals, while the value of serves as the current figure for this metric.
Carmell Corp. (CTCX) - metric breakdowns and financial figures

For an investor in Carmell Corporation (CTCX), this indicator serves as a benchmark for the expansion efficiency of bioactive materials within the regenerative medicine and aesthetics markets. By analyzing the rolling 12-month sales growth versus the same period last year, which calculates the percentage change in revenue over the last four quarters, one can assess the actual pace of market share capture and the fundamental stability of the business's commercial scaling.